Fig. 1From: Mesenchymal stem cell therapies for liver cirrhosis: MSCs as “conducting cells” for improvement of liver fibrosis and regenerationMechanisms of MSCs for liver disease. MSCs have various effects including the reduction of hepatocyte injury and inflammation. Additionally, MSCs affect macrophages and increase matrix metalloproteinase expression and phagocytosis, promoting the regenerative processBack to article page